Peptides Derived from Soy and Lupin Protein as Dipeptidyl-Peptidase IV Inhibitors: In Vitro Biochemical Screening and in Silico Molecular Modeling Study

Journal of Agricultural and Food Chemistry

Volumn 64, Issue 51, 2016, Pages 9601-9606

  Lammi, Carmen ^a   Zanoni, Chiara ^a   Arnoldi, Anna ^a   Vistoli, Giulio ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

bioactive peptide; dipeptidyl peptidase IV inhibitor; lupin; soy; type 2 diabetes

Indexed keywords

BIOASSAY; MOLECULAR MODELING; PEPTIDES; RECOMBINANT PROTEINS;

BIOACTIVE PEPTIDES; DIPEPTIDYL PEPTIDASE IV; INHIBITORY PEPTIDES; LUPIN; MOLECULAR DOCKING; MOLECULAR MODELING STUDIES; MOLECULAR TARGETS; TYPE-2 DIABETES;

PROTEINS;

DIPEPTIDYL PEPTIDASE IV; DIPEPTIDYL PEPTIDASE IV INHIBITOR; PEPTIDE; PLANT PROTEIN;

AMINO ACID SEQUENCE; CHEMISTRY; COMPUTER SIMULATION; HUMAN; KINETICS; LUPIN; MOLECULAR DOCKING; MOLECULAR GENETICS; SOYBEAN;

AMINO ACID SEQUENCE; COMPUTER SIMULATION; DIPEPTIDYL PEPTIDASE 4; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; HUMANS; KINETICS; LUPINUS; MOLECULAR DOCKING SIMULATION; MOLECULAR SEQUENCE DATA; PEPTIDES; PLANT PROTEINS; SOYBEANS;

EID: 85007613541     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/acs.jafc.6b04041     Document Type: Article

References (42)

1. Arnoldi, A.; Zanoni, C.; Lammi, C.; Boschin, G. The role of grain legumes in the prevention of hypercholesterolemia and hypertension Crit. Rev. Plant Sci. 2015, 34, 144-168 10.1080/07352689.2014.897908
2. Ishihara, K.; Oyaizu, S.; Fukuchi, Y.; Mizunoya, W.; Segawa, K.; Takahashi, M.; Mita, Y.; Fukuya, Y.; Fushiki, T.; Yasumoto, K. A soybean peptide isolate diet promotes postprandial carbohydrate oxidation and energy expenditure in type II diabetic mice J. Nutr. 2003, 133, 752-757
3. Oliva, M. E.; Selenscig, D.; D’Alessandro, M. E.; Chicco, A.; Lombardo, Y. B. Soya protein ameliorates the metabolic abnormalities of dysfunctional adipose tissue of dyslipidaemic rats fed a sucrose-rich diet Br. J. Nutr. 2011, 105, 1188-98 10.1017/S0007114510004915
4. Anderson, J. W.; Blake, J. E.; Turner, J.; Smith, B. M. Effects of soy protein on renal function and proteinuria in patients with type 2 diabetes Am. J. Clin. Nutr. 1998, 68, 1347S-1353S
5. Dove, E. R.; Mori, T. A.; Chew, G. T.; Barden, A. E.; Woodman, R. J.; Puddey, I. B.; Sipsas, S.; Hodgson, J. M. Lupin and soya reduce glycaemia acutely in type 2 diabetes Br. J. Nutr. 2011, 106, 1045-51 10.1017/S0007114511001334
6. Lammi, C.; Zanoni, C.; Arnoldi, A. Three peptides from soy glycinin modulate glucose metabolism in human hepatic HepG2 Cells Int. J. Mol. Sci. 2015, 16, 27362-70 10.3390/ijms161126029
7. Roblet, C.; Doyen, A.; Amiot, J.; Pilon, G.; Marette, A.; Bazinet, L. Enhancement of glucose uptake in muscular cell by soybean charged peptides isolated by electrodialysis with ultrafiltration membranes (EDUF): activation of the AMPK pathway Food Chem. 2014, 147, 124-30 10.1016/j.foodchem.2013.09.108
8. Duranti, M.; Consonni, A.; Magni, C.; Sessa, F.; Scarafoni, A. The major proteins of lupin seed: characterisation and molecular properties for use as functional and nutraceutical ingredients Trends Food Sci. Technol. 2008, 19, 624-633 10.1016/j.tifs.2008.07.002
9. Arnoldi, A.; Boschin, G.; Zanoni, C.; Lammi, C. The health benefits of sweet lupin seed flours and isolated proteins J. Funct. Foods 2015, 18, 550-563 10.1016/j.jff.2015.08.012
10. Bertoglio, J. C.; Calvo, M. A.; Hancke, J. L.; Burgos, R. A.; Riva, A.; Morazzoni, P.; Ponzone, C.; Magni, C.; Duranti, M. Hypoglycemic effect of lupin seed gamma-conglutin in experimental animals and healthy human subjects Fitoterapia 2011, 82, 933-938 10.1016/j.fitote.2011.05.007
11. Bailey, C. J.; Tahrani, A. A.; Barnett, A. H. Future glucose-lowering drugs for type 2 diabetes Lancet Diabetes Endocrinol. 2016, 4, 350 10.1016/S2213-8587(15)00462-3
12. Kreymann, B.; Williams, G.; Ghatei, M. A.; Bloom, S. R. Glucagon-like peptide-1 7-36: a physiological incretin in man Lancet 1987, 330, 1300-4 10.1016/S0140-6736(87)91194-9
13. Dupre, J.; Ross, S. A.; Watson, D.; Brown, J. C. Stimulation of insulin secretion by gastric inhibitory polypeptide in man J. Clin. Endocrinol. Metab. 1973, 37, 826-8 10.1210/jcem-37-5-826
14. Nauck, M. A.; Baller, B.; Meier, J. J. Gastric inhibitory polypeptide and glucagon-like peptide-1 in the pathogenesis of type 2 diabetes Diabetes 2004, 53, S190-S196 10.2337/diabetes.53.suppl_3.S190
15. Lynn, F. C.; Pamir, N.; Ng, E. H.; McIntosh, C. H.; Kieffer, T. J.; Pederson, R. A. Defective glucose-dependent insulinotropic polypeptide receptor expression in diabetic fatty Zucker rats Diabetes 2001, 50, 1004-11 10.2337/diabetes.50.5.1004
16. Doupis, J.; Veves, A. DPP4 inhibitors: a new approach in diabetes treatment Adv. Ther. 2008, 25, 627-43 10.1007/s12325-008-0076-1
17. Ahrén, B.; Gomis, R.; Standl, E.; Mills, D.; Schweizer, A. Twelve-and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes Diabetes Care 2004, 27, 2874-80 10.2337/diacare.27.12.2874
18. Carr, R. D. Drug development from the bench to the pharmacy: with special reference to dipeptidyl peptidase-4 inhibitor development Diabet Med. 2016, 33, 718 10.1111/dme.13066
19. Ahrén, B.; Foley, J. E. Improved glucose regulation in type 2 diabetic patients with DPP-4 inhibitors: focus on alpha and beta cell function and lipid metabolism Diabetologia 2016, 59, 907 10.1007/s00125-016-3899-2
20. Fisman, E. Z.; Tenenbaum, A. Antidiabetic treatment with gliptins: focus on cardiovascular effects and outcomes Cardiovasc. Diabetol. 2015, 14, 129 10.1186/s12933-015-0294-0
21. Lacroix, I. M. E.; Li-Chan, E. C. Y. Dipeptidyl peptidase-IV inhibitory activity of dairy protein hydrolysates Int. Dairy J. 2012, 25, 97-102 10.1016/j.idairyj.2012.01.003
22. Lafarga, T.; O’Connor, P.; Hayes, M. Identification of novel dipeptidyl peptidase-IV and angiotensin-I-converting enzyme inhibitory peptides from meat proteins using in silico analysis Peptides 2014, 59, 53-62 10.1016/j.peptides.2014.07.005
23. Lafarga, T.; Rai, D. K.; O’Connor, P.; Hayes, M. A bovine fibrinogen-enriched fraction as a source of peptides with in vitro renin and angiotensin-I-converting enzyme inhibitory activities J. Agric. Food Chem. 2015, 63, 8676-84 10.1021/acs.jafc.5b03167
24. Zhang, Y.; Chen, R.; Ma, H.; Chen, S. Isolation and identification of dipeptidyl peptidase IV-inhibitory peptides from trypsin/chymotrypsin-treated goat milk casein hydrolysates by 2D-TLC and LC-MS/MS J. Agric. Food Chem. 2015, 63, 8819-28 10.1021/acs.jafc.5b03062
25. Zhang, Y.; Chen, R.; Chen, X.; Zeng, Z.; Ma, H.; Chen, S. Dipeptidyl peptidase IV-inhibitory peptides derived from silver carp (Hypophthalmichthys molitrix Val.) proteins J. Agric. Food Chem. 2016, 64, 831-9 10.1021/acs.jafc.5b05429
26. Huang, S.-L.; Jao, C.-L.; Ho, K.-P.; Hsu, K.-C. Dipeptidyl-peptidase IV inhibitory activity of peptides derived from tuna cooking juice hydrolysates Peptides 2012, 35, 114-121 10.1016/j.peptides.2012.03.006
27. Li-Chan, E. C.; Hunag, S. L.; Jao, C. L.; Ho, K. P.; Hsu, K. C. Peptides derived from atlantic salmon skin gelatin as dipeptidyl-peptidase IV inhibitors J. Agric. Food Chem. 2012, 60, 973-8 10.1021/jf204720q
28. Hatanaka, T.; Inoue, Y.; Arima, J.; Kumagai, Y.; Usuki, H.; Kawakami, K.; Kimura, M.; Mukaihara, T. Production of dipeptidyl peptidase IV inhibitory peptides from defatted rice bran Food Chem. 2012, 134, 797-802 10.1016/j.foodchem.2012.02.183
29. Mojica, L.; de Mejía, E. G. Optimization of enzymatic production of anti-diabetic peptides from black bean (Phaseolus vulgaris L.) proteins, their characterization and biological potential Food Funct. 2016, 7, 713-27 10.1039/C5FO01204J
30. Velarde-Salcedo, A. J.; Barrera-Pacheco, A.; Lara-Gonzalez, S.; Montero-Moran, G. M.; Diaz-Gois, A.; Gonzalez de Mejia, E.; Barba de la Rosa, A. P. In vitro inhibition of dipeptidyl peptidase IV by peptides derived from the hydrolysis of amaranth (Amaranthus hypochondriacus L.) proteins Food Chem. 2013, 136, 758-764 10.1016/j.foodchem.2012.08.032
31. Lammi, C.; Zanoni, C.; Arnoldi, A. IAVPGEVA, IAVPTGVA, and LPYP, three peptides from soy glycinin, modulate cholesterol metabolism in HepG2 cells through the activation of the LDLR-SREBP2 pathway J. Funct. Foods 2015, 14, 469-478 10.1016/j.jff.2015.02.021
32. Lammi, C.; Zanoni, C.; Scigliuolo, G. M.; D’Amato, A.; Arnoldi, A. Lupin peptides lower low-density lipoprotein (LDL) cholesterol through an up-regulation of the LDL receptor/sterol regulatory element binding protein 2 (SREBP2) pathway at HepG2 cell line J. Agric. Food Chem. 2014, 62, 7151-9 10.1021/jf500795b
33. Lammi, C.; Zanoni, C.; Arnoldi, A.; Vistoli, G. Two peptides from soy beta-conglycinin induce a hypocholesterolemic effect in HepG2 cells by a statin-like mechanism: comparative in vitro and in silico modeling studies J. Agric. Food Chem. 2015, 63, 7945-7951 10.1021/acs.jafc.5b03497
34. Amigo-Benavent, M.; Clemente, A.; Caira, S.; Stiuso, P.; Ferranti, P.; del Castillo, M. D. Use of phytochemomics to evaluate the bioavailability and bioactivity of antioxidant peptides of soybean β-conglycinin Electrophoresis 2014, 35, 1582-9 10.1002/elps.201300527
35. Lammi, C.; Aiello, G.; Vistoli, G.; Zanoni, C.; Arnoldi, A.; Sambuy, Y.; Ferruzza, S.; Ranaldi, G. A multidisciplinary investigation on the bioavailability and activity of peptides from lupin protein J. Funct. Foods 2016, 24, 297-306 10.1016/j.jff.2016.04.017
36. Lammi, C.; Zanoni, C.; Ferruzza, S.; Ranaldi, G.; Sambuy, Y.; Arnoldi, A. Hypocholesterolaemic activity of lupin peptides: Investigation on the crosstalk between human enterocytes and hepatocytes using a co-culture system including Caco-2 and HepG2 cells Nutrients 2016, 8, 437 10.3390/nu8070437
37. Minkiewicz, P.; Dziuba, J.; Darewicz, M.; Bucholska, J.; Mogut, D. Evaluation of in silico prediction possibility of epitope sequences using experimental data concerning allergenic food proteins summarised in BIOPEP database Pol. J. Food Nutr. Sci. 2012, 62, 151-157 10.2478/v10222-011-0036-2
38. Pedretti, A.; Villa, L.; Vistoli, G. VEGA: a versatile program to convert, handle and visualize molecular structure on Windows-based PCs J. Mol. Graphics Modell. 2002, 21, 47-9 10.1016/S1093-3263(02)00123-7
39. Biftu, T.; Sinha-Roy, R.; Chen, P.; Qian, X.; Feng, D.; Kuethe, J. T.; Scapin, G.; Gao, Y. D.; Yan, Y.; Krueger, D.; Bak, A.; Eiermann, G.; He, J.; Cox, J.; Hicks, J.; Lyons, K.; He, H.; Salituro, G.; Tong, S.; Patel, S.; Doss, G.; Petrov, A.; Wu, J.; Xu, S. S.; Sewall, C.; Zhang, X.; Zhang, B.; Thornberry, N. A.; Weber, A. E. Omarigliptin (MK-3102): a novel long-acting DPP-4 inhibitor for once-weekly treatment of type 2 diabetes J. Med. Chem. 2014, 57, 3205-12 10.1021/jm401992e
40. Korb, O.; Stützle, T.; Exner, T. E. Empirical scoring functions for advanced protein-ligand docking with PLANTS J. Chem. Inf. Model. 2009, 49, 84-96 10.1021/ci800298z
41. Pedretti, A.; Granito, C.; Mazzolari, A.; Vistoli, G. Structural effects of some relevant missense mutations on the MECP2-DNA binding: A MD study analyzed by Rescore+, a versatile rescoring tool of the VEGA ZZ program Mol. Inf. 2016, 35, 424-433 10.1002/minf.201501030
42. Pieter, B. J.-W. Protein hydrolysate enriched in peptides inhibiting DPP-IV and their use. WO 2006/068480 200, 2006.